Hypoxia-specific targets in cancer therapy: role of splice variants
Open Access
- 12 July 2010
- journal article
- editorial
- Published by Springer Nature in BMC Medicine
- Vol. 8 (1) , 45
Abstract
Tumour hypoxia is a well known adverse prognostic factor in the treatment of solid tumours. Hypoxia-inducible factor 1α (HIF-1α), a transcription factor subunit regulating a large number of hypoxia-responsive genes, is considered an attractive target for novel treatment approaches, due to a frequently reported association between HIF-1α overexpression and poor outcome in clinical series. This month in BMC Medicine, Dales et al. report on splice variants of HIF-1α in fresh frozen tissue samples of early human breast cancer, finding an association of mRNA levels of the variant HIF-1αTAG with adverse clinical factors (lymph node status, hormone receptor status) and poor metastasis-free survival. This preliminary study addresses the possibility that specific targeting of individual isoforms resulting from alternative splicing may play a role in HIF-1-directed treatment approaches.Keywords
This publication has 21 references indexed in Scilit:
- Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancerBMC Medicine, 2010
- Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the BlockClinical Cancer Research, 2009
- Role of hypoxia in the hallmarks of human cancerJournal of Cellular Biochemistry, 2009
- Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cellsBMC Cancer, 2007
- The effects of knockdown of wild-type survivin, survivin-2B or survivin-Δ3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditionsCancer Gene Therapy, 2007
- Intermittent Hypoxia Furthers the Rationale for Hypoxia-Inducible Factor-1 TargetingCancer Research, 2007
- CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation ResistanceClinical Cancer Research, 2006
- Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02Journal of Clinical Oncology, 2006
- Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathwayCancer Cell, 2004
- Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinomaCancer, 2003